Melissa Alsina

18.0k citations
221 papers · 6.7k indexed · 1 hit paper · h-index 44
Topics
Multiple Myeloma Research and Treatments (152 papers)Protein Degradation and Inhibitors (74 papers)Cancer Treatment and Pharmacology (39 papers)
Journals
Journal of Clinical InvestigationJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Melissa Alsina

215 papers receiving 6.5k citations

Hit Papers

A phase 2 study of two doses of bortezomib in relapsed or...20042026201120182004100200300400500

Peers

Melissa Alsina
Comparison fields: 5 of 104
  • Hematology 4.6k
  • Molecular Biology 4.1k
  • Oncology 3.3k
  • Genetics 602
  • Immunology 556
Replace Natalie S. Callander with:
Natalie S. Callander United States
Henk M. Lokhorst Netherlands
Laura Rosiñol Spain
Ravi Vij United States
Suzanne Lentzsch United States
Robert Vescio United States
Niels W.C.J. van de Donk Netherlands
Torben Plesner Denmark
Bruno Paiva Spain
Johannes Drach Austria
Melissa Alsina relative to Natalie S. Callander United States Natalie S. Callander's profile →
Citations per field
00.5×1.5×
Natalie S. Callander · 1×
Citations per year

Countries citing papers authored by Melissa Alsina

Since Specialization
Citations

This map shows the geographic impact of Melissa Alsina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Alsina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Alsina more than expected).

Fields of papers citing papers by Melissa Alsina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Alsina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Alsina. The network helps show where Melissa Alsina may publish in the future.

Co-authorship network of co-authors of Melissa Alsina

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Alsina. A scholar is included among the top collaborators of Melissa Alsina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Alsina. Melissa Alsina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 1
5 1
6 8
7 3
8 5
9 66
10 66
11 7
12 4
13 1
14 69
15 119
16 1
17 60
18 90
19 142
20 55

About Melissa Alsina

Melissa Alsina is a scholar working on Hematology, Oncology and Genetics, having authored 221 papers that have together received 6.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (152 papers), Protein Degradation and Inhibitors (74 papers) and Cancer Treatment and Pharmacology (39 papers). The work is most often cited by research in Hematology (4.6k citations), Oncology (3.3k citations) and Molecular Biology (4.1k citations). Melissa Alsina has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Paul G. Richardson, Sundar Jagannath, Kenneth C. Anderson, David S. Siegel, William S. Dalton, Sun Jin Choi, G. David Roodman, James R. Berenson, David Irwin and Kenneth H. Shain. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026